Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Hims & Hers Health in the transaction. Hims & Hers Health, a multi-specialty telehealth platform, announced its acquisition...
Hims & Hers’ Acquisition of 503B Outsourcing Facility MedisourceRx
Backblaze’s IPO
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Backblaze on the deal. White & Case advised Oppenheimer & Co. Backblaze, a provider of cloud storage and...
Theseus Pharmaceuticals’ $160 Million IPO
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Theseus Pharmaceuticals on the deal. Theseus Pharmaceuticals, Inc., a biopharmaceutical company focused on improving the lives of cancer...
TuSimple’s $1.35 Billion Initial Public Offering
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised TuSimple on the deal, while Davis Polk advised the representatives of the several underwriters. TuSimple, a San...